Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05167422 · ClinicalTrials.gov registry record · NA
Trusted Messenger Intervention
A NA study, sponsored by Dartmouth-Hitchcock Medical Center.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT05167422 is a NA study that was terminated before completion, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 2 participants.
The verdict
NCT05167422, a NA study, was terminated before completion, sponsored by Dartmouth-Hitchcock Medical Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
The objective of this pilot study is to develop and evaluate test a trusted messenger intervention targeting vaccine hesitancy in patients on an inpatient psychiatric hospital setting with both acute and chronic patients.
Interventions
- BEHAVIORAL Trusted Messenger
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2021-09-14 |
| Est. Completion | 2023-07-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05167422
The ClinicalTrials.gov registry entry for NCT05167422 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Trusted Messenger is the first listed.
NCT05167422 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05167422 about?
NCT05167422 is a clinical study titled "Trusted Messenger Intervention". The objective of this pilot study is to develop and evaluate test a trusted messenger intervention targeting vaccine hesitancy in patients on an inpatient psychiatric hospital setting with both acute and chronic patients.
What is the current status of trial NCT05167422?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2021-09-14. Estimated completion is 2023-07-14.
What interventions are being tested in trial NCT05167422?
The interventions under investigation include: Trusted Messenger (BEHAVIORAL).
Who is sponsoring clinical trial NCT05167422?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.